| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2299-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1205 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-12 |
| filingDate |
2004-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c364725ae6349b70aabe3a8b4565394
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3002c8c3fcd8e53c058940caa427ddd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edbf7fea241c32b5dc5d9a456f410f2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_071b4611741451413da4d9410187b73c |
| publicationDate |
2005-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2005107298-A1 |
| titleOfInvention |
Crystals and structures of c-Abl tyrosine kinase domain |
| abstract |
The present invention provides machine readable media embedded with the three-dimensional molecular structure coordinates of AblKD and variants and subsets thereof, including binding pockets, methods of using the structure to identify and design affecters, including inhibitors and activator AblKD crystals and compounds and compositions that affect Abl activity. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008067045-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008067045-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006030017-A1 |
| priorityDate |
2003-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |